Refining the Approach to Risk Stratification in Patients With Dilated Cardiomyopathy
- PMID: 34112318
- DOI: 10.1016/j.jacc.2021.04.031
Refining the Approach to Risk Stratification in Patients With Dilated Cardiomyopathy
Keywords: cardiomyopathy; implantable cardioverter defibrillator; risk stratification; sudden cardiac death.
Conflict of interest statement
Funding Support and Author Disclosures Dr. Curtis is an advisory board member for Abbott, Janssen Pharmaceuticals, Sanofi, and Milestone Pharmaceuticals; has received honoraria for speaking from Medtronic, Inc., and Zoll; and is a member of the data monitoring board for Medtronic, Inc. Dr. Khan has reported that he has no relationships relevant to the contents of this paper to disclose.
Comment on
-
Improved Risk Stratification for Ventricular Arrhythmias and Sudden Death in Patients With Nonischemic Dilated Cardiomyopathy.J Am Coll Cardiol. 2021 Jun 15;77(23):2890-2905. doi: 10.1016/j.jacc.2021.04.030. J Am Coll Cardiol. 2021. PMID: 34112317
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
